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Abstract 
Background: The key role of leptin is regulation of appetite and body 
lipid and pregnancy is a condition associated with overeating, 
reduction in heating and adaptation of lipid cells, culminating in 
increased body fat mass. So, this study was conducted to examine the 
relationship between changes in pre-pregnancy BMI and leptin. 
Methods: This Longitudinal study was conducted on 45 women in the 
first trimester of pregnancy using a longitudinal approach and 
convenience sampling method in Tehran city in 2015. The mothers in 
terms of pre-pregnancy BMI were divided into two groups: group A 
(n=22 with normal BMI) and group B (n=23 with high BMI), with 
maternal serum leptin being taken in 6-12 weeks and 15-20 weeks of 
pregnancy and measured by enzyme-linked immunosorbent assay 
(ELISA). The statistical data were analyzed by SPSS V.21 using 
Kolmogorov Smirnov, independent t-test, two-sample Chi square, 
Mann-Whitney, Regression, Pearson and Landa tests with P.V<0.05. 
Results: The mean age of mothers in the present study was 27.47±5.55 
years with a minimum age of 19 and a maximum age of 37 years. The 
mean plasma leptin of the first and second trimesters of pregnancy was 
significantly higher in the high BMI group than in the normal group. 
The correlation showed that the first trimester leptin and changes in 
leptin levels of pregnancy with pre-pregnancy BMI were significantly 
higher in the normal group (P=0.04 and P=0.003). 
Conclusions: BMI before and during pregnancy can be a predictor of 
maternal serum leptin in pregnancy weight gain. 
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Introduction 
The mother's weight as an important health index is closely 
associated with the growth, development, and survival of 
newborns in the future.1 One of the most common methods for 
measuring obesity is the use of body mass index (BMI) which 
is the division of the body weight in kilograms by squared 
height in meters.2 Infertility and menstrual disorders are often 
associated with obesity; the baseline levels of gonadotropins 
and LH responses to gonadotropin secreting hormone (GnRH) 
are related to weight and base metabolism, where weight loss 
reduces plasma leptin, androgens and as a result, LH response 
and ovulation in obese infertile women.3 Pregnancy is a 
condition associated with overeating, reduction in heating and 
adaptation of lipid cells resulting in increased body fat mass. At 
the early stages of pregnancy, the production of fatty acids 
from glucose is increased and the pathways of lipogenesis 
prevail, which seems to be driving hormones such as insulin 
and leptin. On the other hand, at the late stages of pregnancy, 
molecular pathways of lipolysis are more active.4,5 Adipokine 
changes in the maternal circulation in a normal pregnancy 
through changing the maternal weight gain can affect the 
pregnancy complications such as gestational diabetes,6-9 
preeclampsia,10-12 other blood pressure disorders,13,14 late fetal 
death, early delivery, childhood obesity,15-18 and type II 
diabetes in adulthood. Adipokine produced from adipose tissue, 
such as leptin, adiponectin and etc. will play an important role 
in regulating insulin sensitivity, fat metabolism, energy 
stability, and inflammation.19,20 Leptin, a long chained spiral 
protein, belongs to the supernal family of cytokines in group 1 
of ob (obese) gene located on chromosomes 6 and 7, 
structurally similar to the growth hormone, prolactin, 
granulocyte colony-stimulating factor, oncostatin M 3, and 
some interleukins 4.21,22 Adipokine has a range of biological 
activities at two central and peripheral levels including body 
weight regulation,23 energy balance with preventing food 
intake, simulating energy intake,24 satiety,25 affecting the 
glucose and fatty acid metabolism,26-28 affecting insulin 
sensitivity, producing glucocorticoids, osteogenesis, blood 
pressure, embryo development, especially in the maturity of 
pulmonary type II cells for the production of surfactants, onset 
of maturity,29 fertility, pregnancy, and lactation30 in different 
species.22,31-34 Leptin receptor (ob-R) encoded by the diabetes 
gene (db)22,32 has a long isoform Leptin receptor long (LERRL) 
in the hypothalamus, short isoform Leptin receptor short 
(LERRS) in organs and tissues35 and soluble Leptin receptor 
isoform (SolLERR) only in humans.31 Probably, soluble Leptin 
receptor isoforms in pregnancy are responsible for placental 
transfer of leptin for fetal development.36 In this regard, in 
pregnancy, despite the increase in intake of food, and a 
reduction in insulin sensitivity and hyperlipidemia, contrary to 
the usual role of leptin, in order to adapt the mother to 
prolactin, lactose and steroid hormones, this physiological 
resistance is evident in leptin.33,37,38 
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Leptin correlates directly with the total body fat mass such 
that it grows twice in the first trimester of pregnancy.9 
According to the results of Considine and Caro study, serum 
leptin showed a high correlation with lipid mass, and with other 
lipid indicators such as body lipid percentage and body mass 
index.39 Also, the results of Mohammadzadeh et al. study 
revealed a direct and significant correlation between serum 
leptin levels and pelvic, and leptin, and BMI.40 Also, in a study 
by Samolis et al. (2010) in Greece entitled "the relationship 
between serum leptin and BMI of pregnant” pre-pregnancy 
BMI was associated with leptin levels in both groups.41 
Since serum leptin theory has been suggested for weight 
gain during pregnancy in some studies and leptin studies on 
pregnancy in Iran have generally been conducted under 
pathophysiological conditions such as gestational diabetes and 
preeclampsia, therefore, we decided to take a step in 
identifying predictive factors to prevent the occurrence of 
overweight complications during pregnancy by studying the 
relationship between BMI at the beginning of pregnancy and leptin. 
Materials and Methods  
This longitudinal study was conducted on two groups of 
normal BMI (BMI=19/8-26 kg/m2) and overweight mothers 
(BMI=25-29/9kg/m2) in the first trimester who were referred 
for prenatal care in Tehran in 2015. The research site included 
Prenatal Clinic of Mahdieh Hospital, Public Health Centers 
Covered by Shahid Beheshti University of Medical Sciences in 
northern, eastern and southern parts of Tehran such as Shobeir, 
Pourhedayat, Behesht Al-Nabi, Nader, Kadous, Sahib Al 
Zaman, Imam Hasan Mojtaba, Azgul, ImamzadehQasem and 
Chizar. Normal and overweight mothers were taken separately 
through convenient sampling. Serum leptin of the mother’s 
blood samples was measured at Endocrine and Metabolism 
Center Laboratory of Shahid Beheshti University of Medical 
Sciences. The study inclusion criteria included: 1) age: 18-40 
years old, 2) singleton pregnancy, 3) lack of systemic diseases 
such as lupus, diabetes mellitus and thyroid, heart disease, 
kidney disease, coagulation, epilepsy, asthma, hepatitis and 
high blood pressure, 4) the absence of psychological problems, 
death of loved ones and history of using psychiatric drugs, 5) 
no smoking, drug and alcohol abuse, 6) the first trimester of 
pregnancy, and 7) being Iranian. The study exclusion criteria 
included: 1) the presence of any complication of pregnancy 
such as preeclampsia, moles, ectopic pregnancy, diabetes, 
placenta previa and placental abruption, 2) use of any drugs 
other than pregnancy supplements and 3) special diets such as 
vegetarianism and proteinuria. The present study was extracted 
from a Master’s thesis which was financially supported by 
Tarbiat Modarres University of Medical Sciences under the 
ethical code of 5059/52d. 
The sample size was estimated according to Kim's survey 
(2008) in South Korea and Castecano Filho (2013) in Brazil on 
the measurement of leptin in pregnancy42,43 and calculated 
using the formula for measuring the sample size with 95% 
confidence level and test power 0.8: 
S1= Standard deviation of leptin levels in pregnant women 
with normal BMI 
S2= Standard deviation of leptin levels in pregnant women 
with abnormal BMI  
μ1= Mean leptin level in pregnant women with normal 
BMI 
μ2= Mean leptin level in pregnant women with abnormal 
BMI 
Since the sample size at the end of the period is important 
in a cohort study, the sample size was obtained from the 
following formula and estimated as 45 cases taking into 
account the phenomenon of loss to follow up rate (% 59): 
According to previous studies, we knew that the probability 
of loss to follow up was very considerable and as such, the 
study sampling was conducted on 110 pregnant women who 
were eligible to enter the study. During the sampling, the 
mothers were divided into two groups: "the mothers with pre-
natal normal body mass index" (group A) and "the mothers 
with high pre-natal body mass index (overweight and obese)" 
(group B). Due to a large drop rate (two cases of blood 
sampling, immigration or traveling at blood sampling, abortion 
and unwillingness to continue cooperation) in the samples 
during the present longitudinal study, finally the remaining 45 
mothers of the initial number of mothers were studied, with 22 
mothers were being the normal group and 23 in the abnormal 
group. The gestational age was calculated using the first day of 
the last menstruation and if the date was uncertain, the date of 
the first ultrasound in the first trimester of pregnancy was used. 
We explained the process and ensured the mothers about 
having free-cost testing, then after checking entering criteria 
and gaining their written consent, blood sample was taken. The 
mothers were also assured of their personal information 
confidentiality and the researcher's personal contact number 
was given to them by name and position for any midwifery 
telephone counseling. Then, through a standard questionnaire 
form of the prenatal care of the Ministry of Health, 
demographic characteristics, pregnancy history and medical 
history of the mothers were taken with a direct interview with 
them and recorded without mentioning the mother's name as 
encoded information. The maternal weight was recorded by the 
center unit's mechanical scale, while the blood pressure and 
embryo's heart rate were recorded by a digital barometer and 
calibrating Sonicaid by a person respectively. More specialized 
maternal examinations, including thyroid and dental health 
were taken by a specialist of the center and registered in the 
file. BMI was also calculated through dividing the weight (kg) 
by squared height (m²). The pregnant women's nutrition was 
registered using the recommended dietary protocol of the 
ministry of health and training on proper nutrition for prenatal 
care was planned according to the usual method. In each 
prenatal visit, weight, height, BMI and other criteria for 
prenatal care were reviewed such as blood pressure, fetal heart 
sounds and etc. to confirm maternal health. Pregnancy food 
pyramid groups were trained according to the ministry of 
health protocol and According to mothers’ reports, those who 
did not follow the protocol were excluded and only mothers 
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with normal blood pressure were assessed. At the end of each 
visit, the next visit was reminded according to the gestational 
age and, if necessary, Tel follow-up was made to communicate 
more in depth for working with mothers during the study. 
The mother's venous sample was taken in sitting position, 
in two first and second trimesters, preferably left hand 
antecubital vein and rarely from back hand vein and midwifery, 
in order to measure their serum leptin in 6- 12 weeks of  
Gestation between 9 and 11 AM. The samples were sent to 
the laboratory within 48 hours. In the center laboratory, the 
samples were centrifuged with 3000 rpm for 10 minutes and 
plasma was separated, with the serum frozen at low 
temperatures (20 to 70 °C) until the experiment. After 
completing the required sample size in the study, the samples 
were simultaneously measured by ELISA method by a leptin 
specific kit. 
In the present study, a special human leptin kit of Mercodia 
Uppsala (Intraassay CV%: 7.1 with sensitivity of 0.024 ng / ml) 
was purchased from P Teb Co to be employed through ELISA 
method. In accordance with the kit's instructions, the samples 
were diluted 11 times and then the results were multiplied by 
11. The raw data were collected by SPSS V.21 and after 
encoding, they were analyzed by Kolmogorov-Smirnov, 
Regression, Fisher exact test, Independent t-test, Chi-square, 
Pearson and Mann-Whitney and Landa statistics (for RA 
correlation coefficients’ comparison with RB obtained from 
each group at a significance level of P<0.05) tests. 
Results 
The mean age of mothers (n=45) in the present study was 
27.47±5.55 years with a minimum age of 19 and a maximum 
age of 37 years (24.5±5.718 in group A and 29±5.198 in group 
B, P=0.603). A total of 54.5% of the studied mothers were 
between 21 and 30 years of age. Also, 55.5% of mothers had 
diploma and higher education, while 53.3% of spouses had 
diploma and higher education. Further, 95.6% of the mothers 
were housewives, which included all mothers in group A and 
91.3% of the mothers in group B. Most spouses (82.2%) were 
self-employed (86.4% in group A and 78.3% in group B). The 
monthly income of 6.7% of the subjects was poor, 80% was 
average and 13.3% was satisfactory. Also, 31.1% of the 
subjects’ family had 2 members, 60% had three members and 
8.9% had four or more members. Further, 55.6% of the mothers 
had normal delivery and 44.4% had cesarean delivery. Finally, 
33.3% of the subjects were nulligravida and 66.7% of them 
were multigravida with 17.8% of the mothers having also a 
history of abortion. 
The homogeneity of the two groups was confirmed by 
statistical tests in terms of background and demographic 
variables such as age, education and occupation, number of 
households, gender, fertility status, income and type of delivery 
(table 1). 
The normal distribution of variables in each group was 
verified by Kolmogorov-Smirnov statistical test. If the 
distribution was normal, for quantitative variables, independent 
t-test and for qualitative data 2-sample Chi-square test are used. 
For abnormal distribution, Mann-Whitney test was used to 
confirm the homogeneity of the above-mentioned variables. 
 
Table 2. Plasma leptin level (ng/ml) during 1stand 2ndtrimester 
in both groups 
P.V Group B Group A Group 
 mean±SD mean±SD SerumLeptin (ng/ml) 
P=0.01 38.7±15.43 27.05±17.17 1sttrimester Leptin 
P=0.01 25.05±17.7 43±17.22 2ndtrimester Leptin 
P=0.719 3.2±8.3 4.2±7.77 Leptin changes 
Independent t-test 
The mean plasma leptin of the first and second trimester of 
pregnancy was significantly higher in group B than in group A. 
The lowest plasma leptin concentration in the first trimester 
was 5.8 ng / ml while its highest serum concentration was 76.1 
ng / ml in the second trimester.  
Table 1. Distribution of demographic and clinical characteristics of the 
samples 
Variable Normal BMI n(22) 
High BMI 
n(23) P.V 
Education* 
 Elementary school 4 (44.4) 5(55.6) 
P=0.89  High school 5(45.5) 6(54.5) 
 Diploma and Higher education 13(52) 12(48) 
Job** 
 Employed 22(51.2) 21(48.8) 
P=0.16 
 Housewife 0(0) 2(100) 
Number of households** 
 2 members 9(64.3) 5(35.7) 
P=0.36  3 members 11(40.7) 16(59.3) 
 4 and more members 2(50) 2(50) 
Month salary** 
(Iran's Rial) 
 Less than 500,0000 1(33.3) 2(66.7) 
P=0.18  600,0000-1,000,0000 16(44.4) 20(55.6) 
 More than 1,000,0000 5(83.3) 1(16.7) 
Infant sex* 
 Boy 8(40) 12(60) P=0.28 
 Girl 14(56) 11(44) 
Delivery mode* 
 Normal 12(48) 13(52) P=0.89 
 Cesarean 10(50) 10(50) 
Fertility status** 
 Number of pregnancies 
١ 8(53.3) 7(46.7) 
P=0.54 
٢ 8(40) 12(60) 
٣ 
6(60) 4(40) 
 Number of deliveries 
0 9(56.3) 7(43.8) 
P=0.37 1 9(31.9) 14(60.9) 
2 4(66.7) 2(33.3) 
 Number of abortions 
0 18(48.6) 19(51.4) 
P=0.94 
١ 
4(50) 4(50) 
 Number of living born 
0 9(52.9) 8(47.1) 
P=0.9 1 11(45.8) 13(54.2) 
2 2(50) 2(50) 
Chi-square* and fisher exact test** 
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A positive correlation was observed between the first 
trimester leptin level and pre-pregnancy BMI in both groups, 
and this relationship was statistically significant. With an 
increase in pre-pregnancy BMI (kg/m²), leptin concentration in 
the control group was 5.53 ng/ml in the control group and 2.59 
ng/ml in the case group. The correlation of leptin level in the 
first trimester with pre-pregnancy BMI in the control group 
was significantly higher than in the case group.  
Table 3. The relationship between serum leptin levels and pre-pregnancy 
BMI 
Serum Leptin 
(ng/ml) 
pre-pregnancy BMI 
Lambda test Pearson correlation 
Group A Group B 
R (P.V) R (P.V) Lambda statistics (P.V) 
1sttrimester Leptin 0.79 (<0.001) 0.66 (0.001)  1.98 (0.04) 
2ndtrimester Leptin 0.63 (0.02)  0.68 (<0.001)  -0.63 (0.53) 
Leptin changes -0.30 (0.174) 0.08 (0.70) -2.95 (<0.01) 
A positive correlation was observed between the second 
trimester leptin level and pre-pregnancy BMI in both groups, 
and this relationship was statistically significant. With an 
increase in pre-pregnancy BMI (kg/m²), the second trimester 
leptin level in the control group was 4.52 ng/ml and 2.75 ng/ml 
in the case group. Lambda test indicated that the correlation 
between the second trimester leptin level and pre-pregnancy 
BMI was not significantly different between the two groups. 
No significant relationship was found between pre-pregnancy 
BMI and changes in leptin levels in each study group. 
However, the correlation between leptin changes and pre-
pregnancy BMI in the control group was significantly higher 
than in the case group (tables 3). 
Change analysis indicated that one unit increase in BMI 
before pregnancy in the normal group caused one unit decrease 
in changing the leptin level (2ndtrimester leptin minus the 1st 
leptin trimester), while in the abnormal group changes in the 
leptin level caused by one unit increase in BMI was 0.15 
increase (table 4). Regression analysis revealed that the BMI 
before pregnancy had no effect on 2nd trimester leptin 
(regression coefficient= 0.16, 95% CI= (-0.76, 1.08), 
P.V=0.72), but leptin in the 1st trimester was strongly 
associated with leptin levels in the 2nd trimester (regression 
coefficient= 0.94, 95% CI=0.72, 1.16), P.V<0.0001). 
Discussion 
The present study examined the relationship between 
changes in serum leptin levels and BMI. The importance of 
maternal BMI during pregnancy is associated with maternal-
fetal outcomes and post-natal obesity and even childhood of 
neonates of overweight and obese mothers during pregnancy. 
Leptin, as a hormone secreted from adipocytes, is secreted 
by placenta during pregnancy and in many studies, it was 
significantly correlated with maternal pre-pregnancy weight 
and BMI. However, these studies were conducted outside of 
Iran and to some extent reported contradictory results. Most 
studies in Iran have dealt with the relationship between leptin 
and obesity, diabetes, and preeclampsia of mothers; except for 
the present systematic review, no empirical study was found on 
maternal BMI and leptin levels in Iran. 
The mean maternal weight at the first turn of serum leptin 
sampling was 67.25±11.98 kg and 1.33±1.79 kg in the first 
trimester. 
In a study by Gashtasbi et al. in Lolagar and Mahdieh 
hospitals in Tehran, the mean weight gain of the mother was 
13±4.5 kg. In the group of mothers with normal initial BMI, 
this was 13.5±4.1 kg, 13.5±4.1 kg in the overweight group and 
10.8±5.3 kg in the obese group.44 
In a study by Sharifirad et al. (2012) in Isfahan, the mean 
weight gain in pregnancy was 11.73 kg, 13.24±4.34 kg in the 
normal group, 12.76±5.13 kg in the overweight group and 
10.22±7.51 kg in the obese group.45 In a study by Kohdani et 
al. (2010), this mean was 10.1 kg in the case group and 13.9 kg 
in the control group.46,47 In a study by Nasrabadi et al. in north 
and east of Tehran, the mean weight gain during pregnancy in 
the low weight group was 10.1±5.3 kg, 9.1±5.2 kg in the 
normal group and 9.9±6 kg and 9.6±6.3 kg in the overweight 
and obese group, respectively.48 
The mean serum leptin level in the first trimester of the 
mothers of the present study (n=45) was 33.97±17.43 ng/ml. 
In a study by Safdarian (2006) in Tehran, the serum leptin 
level in the beginning of pregnancy by ELISA method was 
14.09±2.2 ng/ml. Also, Khosrobeigi et al. (2013) study in 
Lorestan on 30 healthy pregnant women and 30 women with 
diabetes reported a mean serum non-fasting serum leptin level 
during 24-28 weeks by ELISA method as 30.38±31.56 ng/ml. 
This study was one of the studies with the highest structural 
and study similarity, which reported plasma leptin plasma 
levels close to those of the present study.49,50 In a study by 
Maqboli et al. (2006) in Tehran during 28-42 weeks for 
diabetes screening 527 healthy mothers’ serum leptin by 
ELISA method, it was 20.35±15.15 ng/ml.9 In a study by 
Dabiri (2011) in Zanjan with the aim of evaluating serum leptin 
of 60 preeclampsia pregnant women and normal in preterm 
delivery blocks, the mean level of leptin by ELISA method was 
45.8±34.6 ng/ml.14 In a study by Schubring et al. in the United 
States, non-fasting serum leptin of 57 mothers in 38-42 weeks, 
amniotic fluid and umbilical vein as well as artery of the infant 
during the delivery were measured by Radio-Immuno-Assay 
(RIA) method. The serum leptin (20±13.2 ng/ml) was 
significantly higher than amniotic fluid leptin (3.7±0.8 ng/ml) 
and artery (9.7±9.4) and vein (8.9±8.6) of the umbilical cord.4 
In a study by Heland et al. in the United States, serum leptin 
levels in pregnant women in 18 and 35 weeks and in their 
newborns were measured by RIA. They observed that that the 
serum leptin level was 15.5±9 in 18 weeks, 17.7±10.7 μg/l in 
35 weeks, which also showed a positive correlation with pre-
pregnancy BMI of mothers.51 Elsewhere, in Lea's study in 
USA, the that leptin in the umbilical cord after overnight 
fasting before cesarean delivery was measured by ELISA 
method in 49 women in 35-41 weeks, with mean levels found 
in the normal group (1.75 ng/ml).52 The study by Butte et al. in 
California was conducted to measure the serum leptin in 
pregnant and lactating women on 65 pregnant women in 36 
weeks and 3 to 6 months after delivery and the mean serum 
leptin with 12-hour fasting by ELISA method was 29.8±17 
ng/ml 36 weeks, 18±15.2 ng/ml 3 months and 18±15 ng/ml 6 
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months after delivery, with serum leptin being significantly 
correlated with pre-pregnancy weight.3 
In a study by Mumtaz et al. (2008) in Pakistan on non-
fasting serum leptin of 40 normal mothers and preeclampsia in 
the third trimester of pregnancy, the mean leptin of the normal 
group of the study with RIA method was 27.82±1.05 ng/ml.10 A 
study by Stein et al. on 103 normal pregnant women in the 
United States reported leptin, for the first trimester as 19±1 and 
28.6±1.1 μg/l for 28-week leptin, respectively.53 In a study by 
Samolis (2010) in Greece, leptin of the first trimester (up to 13 
weeks) on 37 pregnant women a mean level was 2.502 ng/ml.41 
In a study by Colcimea (2015) in Turkey on plasma non-fasting 
leptin of 30 normal pregnant women during 34-42 weeks by 
ELISA method, the mean serum leptin concentration was 
3.1±3.1 ng/ml.54 In a study by Saylik et al. (2009) in Turkey, 
again the serum leptin of mothers who were hospitalized for 
delivery after 6-8 hour fasting, using EASIA method in the 
normal group was 8.5±6.9 ng/ml.55 
Many differences were observed in the results of 
pregnancy-related leptin concentration in studies and no single 
definite reason can be mentioned. Nevertheless, their 
examination in various fluids in the body, such as plasma, 
umbilical cord, cerebrospinal fluid and even follicular fluid, 
can be explained as reasons for the differences. For example, 
the concentration of leptin in the cerebrospinal fluid was 100 
times lower than the plasma leptin.56 The differences in the 
design and collection time, leptin measurements in different 
weeks of pregnancy, various methods and brands of assay kits 
in leptin analysis, differences in inclusion and exclusion criteria 
of samples, sample size differences, non-fasting and fasting 
status of mothers, breasts, geographic climates and even the 
type of mothers' diet in the studies can be the possible reasons 
for the different reported means. 
In the present study, serum leptin levels of the first and 
second turns with maternal pre-pregnancy BMI were 
statistically significant. With comparing the two groups, it was 
found that the correlation between the first trimester leptin and 
pre-pregnancy BMI showed a significant difference between 
the two groups. A study by Kim et al. (2008) in South Korea 
examined plasma leptin of 75 pregnant women in the first and 
third trimesters of pregnancy and 6 months after delivery with a 
12-hour fasting by ELISA method. According to the results, the 
first trimester leptin showed a significant correlation with BMI 
and was a predictor of birth weight.42 A study by Lu et al. in 
China on 50 pregnant women between 37 and 38 weeks of 
gestation showed a significant relationship between leptin, 
weight, and BMI, with the mean serum leptin concentration 
being 13.62±3.68 μg/l.57 
Filho performed a two-group cohort study in Brazil, with a 
similar research structure to the present study on 42 low-risk 
pregnant women. The serum non-fasting leptin was measured 
by ELISA method and a significant relationship was found 
between serum leptin changes and BMI before the maternal 
pregnancy.43 Aguilar-Moreno study (2015) in Spain tested 71 
pregnant women aged 18-24 years old. The serum leptin levels 
in adolescent mothers were not statistically significant 
compared to older mothers. Leptin was significantly associated 
with all anthropometric indicators of the samples such as the 
body weight, body fat percentage, BMI, hip circumference and 
wrist circumference.58 
In the present study, due to the significant correlation 
between prenatal BMI, leptin of the first trimester and its serum 
changes between the two groups, the serum leptin levels of 
mothers during pregnancy can be attributed to pre-pregnancy 
body fat mass, which is due to the endocrine role of adipose 
tissue to secrete leptin. 
According to the results of the present study, the first 
trimester plasma leptin of pregnant women had a significant 
correlation with pre-natal BMI. It can be concluded that the 
determinant factor in maternal plasma leptin hormones in 
pregnancy is pre-pregnancy BMI. This BMI can be a predictor 
of maternal serum leptin and subsequently weight gain during 
pregnancy. 
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